Non-invasive Biomarker Test for Gastric Cancer Diagnosis
Biomarker REC8 for Diagnosis and Prognosis of Gastric Cancer
Tags: The Chinese University of Hong Kong, Hong Kong, Healthcare & Lifesciences
This technology introduces REC8 as a novel biomarker for the non-invasive diagnosis and prognosis of gastric cancer. A molecular test quantifies methylated and unmethylated REC8 alleles in patient samples, providing a more sensitive and specific diagnosis than current methods. The test also has strong prognostic value, correlating REC8 methylation with patient survival. Applications include routine clinical use for gastric cancer diagnosis and monitoring. The technology offers a highly accurate, non-invasive approach for managing gastric cancer.
IP Type or Form Factor: Patent Granted; Material; Device
TRL: 6 - prototype validated in intended environment
Industry or Tech Area: Diagnostics & Screening; Healthcare Provider
